News of the WeekCHINESE DRUG RESEARCH

Novartis Invests $100 Million in Shanghai

+ See all authors and affiliations

Science  17 Nov 2006:
Vol. 314, Issue 5802, pp. 1064-1065
DOI: 10.1126/science.314.5802.1064b

You are currently viewing the summary.

View Full Text

Summary

SHANGHAI-- Many big pharmaceutical companies have outsourced specific steps in the drug discovery process to China. But Novartis, the Swiss drug giant, is building a $100 million R&D center here that "will encompass all stages of drug development, from early discovery all the way to clinical trials." (Read more.)

Related Content